Levofloxacin Preventive Therapy for Children Living with Adults with MDR-TB: Evidence-Based Medicine Viewpoint. - Suppr | 超能文献

Levofloxacin Preventive Therapy for Children Living with Adults with MDR-TB: Evidence-Based Medicine Viewpoint.

作者信息

Mathew Joseph L

机构信息

Advanced Pediatrics Centre, PGIMER Chandigarh, Chandigarh, 160012, India.

出版信息

Indian Pediatr. 2025 Apr;62(4):306-309. doi: 10.1007/s13312-025-00069-7.

DOI:10.1007/s13312-025-00069-7

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Levofloxacin Preventive Therapy for Children Living with Adults with MDR-TB: Evidence-Based Medicine Viewpoint.

Indian Pediatr. 2025 Apr;62(4):306-309. doi: 10.1007/s13312-025-00069-7.

2

Levofloxacin Preventive Therapy for Children Living with Adults with MDR-TB: Pediatric Tuberculosis Specialist's Viewpoint.左氧氟沙星对与耐多药结核病成年人共同生活儿童的预防性治疗：儿科结核病专家观点

Indian Pediatr. 2025 Apr;62(4):310-311. doi: 10.1007/s13312-025-00068-8.

3

Levofloxacin versus placebo for the prevention of tuberculosis disease in child contacts of multidrug-resistant tuberculosis: study protocol for a phase III cluster randomised controlled trial (TB-CHAMP).左氧氟沙星与安慰剂预防耐多药结核病儿童接触者结核病：一项III期整群随机对照试验（TB-CHAMP）的研究方案

Trials. 2018 Dec 20;19(1):693. doi: 10.1186/s13063-018-3070-0.

4

A Meta-Analysis of Levofloxacin for Contacts of Multidrug-Resistant Tuberculosis.左氧氟沙星用于耐多药结核病接触者的荟萃分析。

NEJM Evid. 2025 Jan;4(1):EVIDoa2400190. doi: 10.1056/EVIDoa2400190. Epub 2024 Dec 18.

5

Practical and psychosocial challenges faced by caregivers influence the acceptability of multidrug-resistant tuberculosis preventive therapy for young children.照顾者面临的实际和心理社会挑战会影响幼儿耐多药结核病预防性治疗的可接受性。

PLoS One. 2022 Jul 14;17(7):e0268560. doi: 10.1371/journal.pone.0268560. eCollection 2022.

6

Levofloxacin Preventive Treatment in Children Exposed to MDR Tuberculosis.左氧氟沙星对接触耐多药结核病儿童的预防性治疗

N Engl J Med. 2024 Dec 19;391(24):2315-2326. doi: 10.1056/NEJMoa2314318.

7

Explorative Analysis of Treatment Outcomes of Levofloxacin- and Moxifloxacin-Based Regimens and Outcome Predictors in Ethiopian MDR-TB Patients: A Prospective Observational Cohort Study.基于左氧氟沙星和莫西沙星方案的埃塞俄比亚耐多药结核病患者治疗结果及结果预测因素的探索性分析：一项前瞻性观察队列研究。

Infect Drug Resist. 2021 Dec 18;14:5473-5489. doi: 10.2147/IDR.S342964. eCollection 2021.

8

Acceptability of a 250 mg levofloxacin formulation in children receiving TB preventive treatment.250毫克左氧氟沙星制剂在接受结核病预防性治疗儿童中的可接受性。

IJTLD Open. 2025 Mar 12;2(3):129-136. doi: 10.5588/ijtldopen.24.0569. eCollection 2025 Mar.

9

Tuberculosis Diagnosis and Preventive Monotherapy Among Children and Adolescents Exposed to Rifampicin-Resistant Tuberculosis in the Household.家庭中接触耐利福平结核病的儿童和青少年的结核病诊断与预防性单药治疗

Open Forum Infect Dis. 2023 Feb 21;10(3):ofad087. doi: 10.1093/ofid/ofad087. eCollection 2023 Mar.

10

Update on multidrug-resistant tuberculosis preventive therapy toward the global tuberculosis elimination.耐多药结核病预防治疗对全球消除结核病的最新进展。

Int J Infect Dis. 2025 Jun;155:107849. doi: 10.1016/j.ijid.2025.107849. Epub 2025 Feb 22.

本文引用的文献

1

Levofloxacin Preventive Treatment in Children Exposed to MDR Tuberculosis.左氧氟沙星对接触耐多药结核病儿童的预防性治疗

N Engl J Med. 2024 Dec 19;391(24):2315-2326. doi: 10.1056/NEJMoa2314318.